NCT06537739

Brief Summary

The aim of the study is to evaluate the influence of verbal suggestion on the therapeutic effect of the joint manipulation of the lumbar spine in patients with chronic non-specific low back pain in relation to the pain level, stress, disability, function, sleepiness, tissue temperature and selected blood biochemical markers. The study participants will be randomly assigned (sealed allocation envelopes) to the following groups:

  • Group A (test intervention + placebo communication)
  • Group B (test intervention + nocebo communication)
  • Group C (test intervention + neutral communication) The study will mainly consist of the three stages, i.e. before the intervention, immediately after the intervention and 24 hours later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 14, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

2 months

First QC Date

July 31, 2024

Last Update Submit

February 4, 2025

Conditions

Keywords

Back PainMusculoskeletal ManipulationsNocebo EffectPlacebo Effect

Outcome Measures

Primary Outcomes (1)

  • Numerical Rating Scale (NRS)

    The participant gives a score expressed in numbers from 0 to 10

    Before the intervention, immediately after the intervention and 24 hours later

Secondary Outcomes (14)

  • Tampa Scale of Kinesiophobia (TSK)

    Before the intervention, immediately after the intervention and 24 hours later

  • Back Pain Function Scale (BPFS)

    Before the intervention, immediately after the intervention and 24 hours later

  • Perceived Stress Scale (PSS-10)

    Before the intervention, immediately after the intervention and 24 hours later

  • Stress Numerical Rating Scale-11

    Before the intervention, immediately after the intervention and 24 hours later

  • Roland-Morris Disability Questionnaire (RMDQ)

    Before the intervention, immediately after the intervention and 24 hours later

  • +9 more secondary outcomes

Study Arms (3)

Group A (test intervention + placebo communication)

EXPERIMENTAL

Participants who will undergo the joint manipulation of the lumbar spine region and receive positive communication - placebo.

Other: Lumbar manipulationOther: Positive communication - placebo

Group B (test intervention + nocebo communication)

EXPERIMENTAL

Participants who will undergo the joint manipulation of the lumbar spine region and receive negative communication - nocebo.

Other: Lumbar manipulationOther: Negative communication - nocebo

Group C (test intervention + neutral communication)

OTHER

Participants who will undergo the joint manipulation of the lumbar spine region and receive neutral communication.

Other: Lumbar manipulationOther: Neutral communication

Interventions

Participant lies in the supine position, a physiotherapist faces the participant's side that will be manipulated. The participant interlocks their fingers behind their neck. Then the physiotherapist turns the participant on their side and performs a short thrust across the participant's pelvis in a posterior and inferior direction. The manipulation will be carried out on the symptomatic side, based on the participant's indication of the painful side. If the participant is unable to indicate the more symptomatic side, the physiotherapist performing the procedure will select the side. If no audible cavitation occurs during the manipulation, the physiotherapist will attempt to manipulate the opposite side. A maximum of 2 attempts per side will be allowed.

Group A (test intervention + placebo communication)Group B (test intervention + nocebo communication)Group C (test intervention + neutral communication)

Participants from Group A who will undergo the joint manipulation of the lumbar spine region and receive the following information: "Joint manipulation is a very effective method of treating spinal disorders, which will significantly reduce the low back pain you are experiencing" (positive communication - placebo).

Group A (test intervention + placebo communication)

Participants form Group B who will undergo the joint manipulation of the lumbar spine region and receive the following information: "Joint manipulation is not an effective method of treating spinal disorders, thus it may temporarily increase the low back pain you are experiencing" (negative communication - nocebo).

Group B (test intervention + nocebo communication)

Participants from Group C who will undergo the joint manipulation of the lumbar spine region and receive the following information: "Joint manipulation has not been verified for its effectiveness in affecting your level of low back pain" (neutral communication).

Group C (test intervention + neutral communication)

Eligibility Criteria

Age19 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • participants with low back pain lasting more than 3 months,
  • participants who have not been taking any non-steroidal anti-inflammatory drugs (NSAIDs) for at least one week prior to the start of the study,
  • participants who are not taking any steroid drugs,
  • participants who have never had the joint manipulation before,
  • participants within the age range of 19-30 years,
  • written consent to participate in the study.

You may not qualify if:

  • participants who are students of physiotherapy,
  • participants with a BMI \>33,
  • participants after a lumbar spine surgery,
  • participants who, in the 6 months prior to the start of the study, suffered from a lumbar spine injury,
  • participants with diabetes,
  • participants with rheumatic diseases,
  • participants with endometriosis,
  • participants with endocrine diseases,
  • participants with acute inflammation in the lumbar spine region and sciatica symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

John Paul II University in Biała Podlaska

Biała Podlaska, Lublin Voivodeship, 21-500, Poland

Location

MeSH Terms

Conditions

Back Pain

Interventions

Manipulation, Spinal

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Kamil Zaworski, Ph.D.

    John Paul II University in Biała Podlaska

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants will be randomly assigned to groups. One of the researchers will then give the person a verbal message (dependent on the study group). The physiotherapist performing the joint manipulation will not know which study group a given patient belongs to. The researcher collecting results and performing statistical analysis will also be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: It will be a prospective follow-up study, with a type of message used as a differentiating variable (positive - placebo, negative - nocebo, neutral).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2024

First Posted

August 5, 2024

Study Start

October 14, 2024

Primary Completion

December 16, 2024

Study Completion

January 31, 2025

Last Updated

February 6, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Analytical data will be available through direct contact with the research team and in the publication process as supplementary materials.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
From the completion of the research for the next five years.
Access Criteria
Direct contact with the research team.

Locations